Detalhe da pesquisa
1.
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.
Blood
; 141(3): 295-308, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260765
Mostrar mais
Texto completo
Documentos relacionados
2.
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Lancet Oncol
; 25(3): 388-399, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423051
3.
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.
Blood
; 139(23): 3366-3375, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081255
4.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Blood
; 140(17): 1845-1857, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917453
5.
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.
Blood
; 139(24): 3546-3557, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286378
6.
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722621
7.
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.
Blood
; 138(5): 387-400, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351368
8.
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia.
Ann Hematol
; 102(11): 3049-3059, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702821
9.
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.
N Engl J Med
; 380(17): 1628-1637, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018069
10.
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.
Haematologica
; 107(5): 1034-1044, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261293
11.
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes.
Ann Hematol
; 101(8): 1689-1701, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488900
12.
MDM2 and BCL-2: to p53 or not to p53?
Blood
; 141(11): 1237-1238, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929437
13.
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.
Blood
; 141(12): 1489-1493, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493344
14.
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study.
Ann Hematol
; 99(9): 2119-2124, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676733
15.
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 114(23): E4641-E4647, 2017 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533390
16.
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019.
J Natl Compr Canc Netw
; 17(5): 414-423, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085755
17.
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(6): 721-749, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200351
18.
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 19(7): 889-903, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29859851
19.
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.
Blood
; 128(13): 1671-8, 2016 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27421961
20.
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results.
Am J Hematol
; 93(11): 1301-1310, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30074259